Skip to main content
Livermore
Livermore
ZHEN

Horizon Therapeutics Public Ltd Co

HZNPDelisted Oct 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001492426

Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.

Superinvestors holding HZNP, Q3 2023

1 superinvestor reports holding Horizon Therapeutics Public Ltd Co on Form 13F, worth $380.6M in total. Weight is Horizon Therapeutics Public Ltd Co's share of each 13F portfolio; actions compare shares with Q2 2023.

See all superinvestors
Superinvestors holding HZNP in Q3 2023
Superinvestor% of portfolioSharesValuevs. previous quarter
Soros Fund ManagementGeorge Soros7.8%3,289,584$380.6MReduced−0.1%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of HZNP each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q3 2023

    1 superinvestor holding at quarter end

    Reduced
    Soros Fund Management (−0.1%)
    Sold out
    Abrams Capital, Third Point

  2. Q2 2023

    3 superinvestors holding at quarter end

    New
    Abrams Capital, Third Point

  3. Q1 2023

    1 superinvestor holding at quarter end

    Added
    Soros Fund Management (+15.2%)

  4. Q4 2022

    1 superinvestor holding at quarter end

    New
    Soros Fund Management

  5. Q3 2021

    0 superinvestors holding at quarter end

    Sold out
    Viking Global Investors

  6. Q2 2021

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−44.7%)